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ABSTRACT:  The immunomodulatory property of plants is being studied with greater interest in 
recent years.  This is more so because of the growing awareness regarding the need to modulate 
the immune system to achieve the desirable effects of preventing an infection rather than treating 
it at an advanced state.  The recent advances in this field are summarized in this article. 
 
INTRODUCTION 
 
The basic function of immune system is to 
detect and destroy the non-self and thus a 
defence mechanism.  The system works 
throughout the body through an intricate 
regulation of cellular and humoral factors.   
Its protective task, starting with the 
recognition of non-self bodies and 
substances puts the immune system in a vital 
position between a healthy and diseased 
state of the host. 
 
The concept of immunomodulation, in its 
modern sense, was developed by Lazarev, 
referring to the non-specific resistance 
increasing property of diabazol
1.  In recent 
years, the field of immunomodulation 
attracted  attention from the scientific 
community, in view of the growing 
awareness regarding the need to modulate 
the immune system to achieve the desirable 
effects of preventing an infection rather than 
treating it at an advanced state. 
 
IMMUNOMODULATION 
 
An immunomodulator is defined
2,3  as a 
biological or non-biological substance that 
directly influences a specific immune 
function or modifies one or more 
components of immunoregulatory network 
to achieve an indirect effect on a specific 
immune function. 
 
A number of clinical conditions, like 
cancer
4,5, surgery
6  or administration of 
drugs
7  are known to affect the different 
components of the immune system, thereby 
making the host susceptible to infections.   
Also, stress, be it physical or psychological, 
causes immunosuppression
7.  Such are the 
situations, which call for immunostimulant 
drugs to boost the immune defences against 
the host.  The result has been the 
development of the concept of “pro-host 
therapy”
8  and administering drugs, like 
glucans
9-11, muramyl dipeptide
12, 
interleukin-1
13  and colony stimulating 
factors
14, to enhance the non-specific host 
resistance against infections
15.  However, 
the major drawbacks of these substances are 
their prohibitive cost and development of 
local reactions like granuloma formation. 
 
As opposed to the need for 
immunostimulants, there also are cases of 
immune-hypersensitivity reactions, such as 
asthma, autoimmunity, graft rejection, 
arthritis, allergy and inflammatory disorders, 
in which an immuno-suppressor is 
indicated
16.  Most of such agents in clinical Pages 326 - 331 
use are the cytotoxic drugs such as 
azathioprine
17, cyclophosphamide
18, 
prostaglandins
19, cyclosporine A
20, 
thicarbomate
21, levamisol
22, niridazole
23 and 
pencillamine
24.  The main disadvantage of 
these drugs is their cytotoxicity and 
associated side effects. 
 
Against this background, the use of herbal 
drugs, to restore and rejuvenate positive 
health and to maintain organic balance, has 
been in vogue since ancient times and the 
rasayana  therapy in Ayurvedic medicine
25 
encompasses many plant preparations which 
have been used as tonic drugs. 
 
In this paper, an effort has been made to 
elaborate the current trends in the 
investigations on the immunomodulators of 
plant origin. 
 
IMMUNOMODULATORY STUDIES 
 
Literature survey shows that there is a spurt 
in the past few years, in research on 
immunomodulators of plant origin.  A 
number of plants of known therapeutic 
properties are evaluated on a battery of 
experiments to identify their mechanism of 
action at the molecular level. 
 
Labadie et al evolved the new concepts in 
ethno-pharmacognosy through basic and 
field enquiries into the literature and practice 
of traditional Indian medicine.  In the their 
integrated studies on immunomodulating 
properties ofAzadirachta indica  bark, 
Woodfordia fructicosa flowers, Picrorrhiza 
kurroa  roots and Jatropha multifida  latex, 
the data was collected on ethnobotanical, 
ethnopharmacological, ethnopharmaceutical 
and ethnomdeical aspects, and the 
experimental immunopharmacognostic 
phase was carried out by isolating and 
purifying compounds through activity-
guided fractionation in human complement 
and PMN leucocyte activation 
experiments
26. 
 
The inhibition of complement activation and 
luminal-dependent chemiluminescence by 
A.indica was proposed
27,28, to be in in-vitro 
correlate of its anti-inflammatory and anti-
rehumatoidal effects, for which it is widely 
used.  The stimulation of lymphocyte 
function, as shown by dose-dependent 
increase in production of migration 
inhibition factor (MIF), might be an 
underlying factor in the general stimulating 
and skin-healing properties of A.indica.  In 
the recent studies
29, gallic acid, (+)-
gallacatechin, (-)-epicatechin, and (+)-
catechin were isolated from A.indica  in 
activity-guided fractionation studies. 
 
The polysaccharides from the roots of Panax 
ginseng have been used clinically as an anti-
tumor drug in China.  Recent studies
30 have 
revealed that the anti-tumor polysaccharides 
also have anti-complementary activity and 
that the polysaccharides from the leaves of 
P.ginseng show higher anti-complementary 
activity than those from the roots. 
 
The immuno-suppressant property of 
5,20_(R)-Dihydroxy-6_, 7_-epoxy-1-oxo-
(5_)-with a-2, 24-dienolide from Withania 
somnifera  and the steroidal alkaloid 
solasodine from Solanum nigrum,  in 
inhibiting  the proliferation of spleen cell 
culture, are supposed to be responsible for 
the activity of these plants in curing 
rheumatism, asthma and various skin 
affections including carbuncles and 
obstinate ulcers
31. 
 
The would-healing activity of Aloe vera 
leaf-gel was sought to be explained on the 
basis of the immuno-modulatory activity of 
the  polysaccharide fractions isolated from 
it
32,33.  The polysaccharides displayed 
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production and the induction of delayed type 
hypersensitivity in mice
33. 
 
Root extract of Picrorrhiza kurroa was 
fractionated on the basis of the inhibition of 
zymosan-induced chemiluminescence.  The 
components responsible for the activity were 
indentified to be apocynin, vanillic acid and 
picroside II
34. 
 
The anti-inflammatory activity of 
Glycyrrhiza glabra was found to be due to 
its constituent glycerrhizin, which acted by 
significantly inhibiting the generation of 
reactive oxygen  species (ROS) by 
neutrophils, the most potent inflammatory 
mediators at the site of inflammtion
35. 
 
The immuno-modulatory activity of 
polysaccharides isolated from  Arnica 
Montana  was revealed in carbon-clearance 
test and in stimulation of macrophages to 
excrete tumor necrosis factor
36. 
 
The immuno-modulatory activity of Piper 
betle  leaves,  Zingiber aramatica  rhizome, 
Allium sativum  and  Andrographis 
paniculata  was  displayed by their 
stimulation of humoral immune response by 
the “microtitration hematoglutinin test” and 
suppression of cellular immune response by 
delayed hypersensitivity test.  It was also 
noted that their water-soluble and water-
insoluble portions exhibited opposite results 
on phagocytic activity by carbon clearance 
test
37. 
 
 The recent trend in evaluation of the 
immunomodulators of plant origin is 
towards assessing the activity profile of the 
isolated principles in a battery of 
experiments with a view  to identify the 
components responsible for the activity as 
also to understand the mechanism of their 
action.  Amongst diverse class of 
compounds, it was observed that flavonol 
series possess the most potent anti 
complementary activity
38.  The Citrus 
flavonoids were found to be very active 
inhibitions of basophil histamine release and 
neutrophil ß-glucuronidase release, thus 
exhibiting the in-vitro correlate of their anti-
allergic and anti-inflammatory activity
39.  
(+)-Dihydroquercetin was found to be a less 
potent inhibitor of competent activity, 
compared to that of (+)-catechin, (-)  -
epicatechin and acetylsalicylic acid
40.  
Flavonoids have exhibited immunostimulant 
activities too.  Flavonie-acenostimulant 
activities too.  Flavonie – acetic acid (FAA), 
a C-8 substituted flavone derivative, has 
been shown to cause significant regression 
in a variety of murine tumor models, caused 
significant lymphocyte proliferation as well 
as increase in phagocytosis of zymosan
41.  
The potent anti-phlogistic and anti-allergic 
activity of the flavonid Wedelolactone from 
Eclipta alba and Wedelia calendulaceae was 
found to be due to its 5-lipoxygenase 
inhibitory activity, suggesting that it acts by 
free oxygen radical scavenger 
mechanism
42,43. 
 
Studies have also accounted for the tonic 
properties of plants like A.indica, 
Holarrhena antidysenterica, Aconitum 
heterohyllum, Tylophora asthmatica, 
Ocimum gratissimum and  Tinospora 
cordifolia, in stimulation of lymphocytic and 
phagocytic function and inhibition of 
humoral components of the immune 
system
44-46. 
 
In the preliminary studies on the immuno-
potentiating action of some Ayurvedic 
drugs
47  like  Kanjanara gulgulu, Rasa 
sinduram and Khadirarishtam, administered 
to cancer patients, it was found that the T-
cell count showed a slight enhancement after 
the treatment. 
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The significant aspect of the bioavailability 
of active constituents in traditional 
preparations was studied in case of the 
Ayurvedic drug Nimba arishta; wherein the 
flowers of Woodfordia fructicosa  were 
found to be important ingredient of Kalka 
(paste), which is added to the decoction of 
A.indica, with respect to the modulation of 
complement activity
48. 
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